Case Western Reserve University and the National Foundation for Cancer Research (NFCR) established a new NFCR Center for Molecular Imaging. This center, funded by a five-year grant from the NFCR, will focus on assisting cancer scientists in identifying specific genes that are ideally suited for molecular imaging and diagnosis improvement that will lead to earlier-stage treatments for cancer patients.
“Molecular imaging is being recognized as the next revolution in cancer research and is paving the way for patient-specific imaging evaluation, based on molecular and genetic markers,” says James P. Basilion, Ph.D., who will lead the NFCR and is associate professor of radiology and biomedical engineering at Case.
By collaborating with over 40 additional cancer researchers at universities and hospitals worldwide, the NFCR Center for Molecular Imaging at Case will provide an imaging and diagnostic research platform for scientists in the early diagnosis and clinical development of novel anticancer drugs.
The Case center joins other NFCR Centers established at Oxford, Yale, University of Alabama-Birmingham, University of California-Berkeley, Dana Farber Cancer Institute, University of Arizona, Freie Universitat Berlin, and the Institute of Medicinal Biotechnology in Beijing to form a broader international collaborative network of top researchers.
